Back to Results

Pharma-Bio Serv Inc (PBSV)

Pharma-Bio Serv Inc is a common stock listing on OTC Markets for a healthcare-sector company focused on regulatory affairs, compliance, and technology transfer consulting. Based in Dorado, Puerto Rico, the company provides technical support across areas such as quality assurance, validation, engineering, project management, process support, and related compliance functions. Its services are directed to clients in the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, and food industries, as well as allied product companies. Founded in 1993, Pharma-Bio Serv also serves customers in Puerto Rico, the United States, Europe, Brazil, and other international markets.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-PBSV
$0.60
19.7% Upside
Undervalued
$1.55
210.0% Upside
Bargain
Fair
—
—
0.08
15.0%
September 16, 2026
186.2x
1.1x
1.3x
11.451 M
2.979 M
0.0%
36.6%
9.4
2,793.2%
-400.7%
Valuation • Fair Value

Pharma-Bio Serv Inc (OTC-PBSV) Fair Value by Valuation Model

Compare the primary fair value estimate for Pharma-Bio Serv Inc (OTC-PBSV) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.60

Estimated upside of 19.7% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0.030

Classic Ben Graham valuation formula reference.

DDM Fair Value

$0.65

Dividend discount model valuation reference.

EPV Fair Value

$0.64

Earnings power value estimate.

Comps Fair Value

$0.58

Comparable-company valuation reference.

Analyst Price Target

$1.55

Analysts imply upside of 210.0%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Pharma-Bio Serv Inc (OTC-PBSV) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Pharma-Bio Serv Inc (OTC-PBSV)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

9.111 M

Current operating scale indicator.

Revenue Forecast

11.7 M

Forward revenue estimate.

EBITDA

-337.011 K

Current operating profitability reference.

EBITDA Forecast

4.787 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Pharma-Bio Serv Inc (OTC-PBSV) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Pharma-Bio Serv Inc (OTC-PBSV)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.47

No elevated caution signal from this screen.

Altman Z-Score

9.4

Relatively strong balance-sheet zone.

FCF / Net Income

-400.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Pharma-Bio Serv Inc (OTC-PBSV). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Pharma-Bio Serv Inc (OTC-PBSV)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 16, 2026

Days to Earnings

57

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

15.0%

Income yield reference.

Upcoming Dividend

0.08

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

2,793.2%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Pharma-Bio Serv Inc (OTC-PBSV), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Pharma-Bio Serv Inc (OTC-PBSV) Stock Forecast & Technical Outlook

Review Pharma-Bio Serv Inc (OTC-PBSV) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Pharma-Bio Serv Inc (OTC-PBSV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Pharma-Bio Serv Inc (OTC-PBSV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Pharma-Bio Serv Inc (OTC-PBSV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Pharma-Bio Serv Inc (OTC-PBSV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Pharma-Bio Serv Inc (OTC-PBSV) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Pharma-Bio Serv Inc (OTC-PBSV)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Pharma-Bio Serv Inc (OTC-PBSV) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Pharma-Bio Serv Inc (OTC-PBSV) Stock FAQ

Quick answers about Pharma-Bio Serv Inc (OTC-PBSV) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.60
Estimated upside 19.7%
Valuation Rating
Undervalued
Estimated upside of 19.7%
Analyst Target
$1.55
Implied upside 210.0%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Pharma-Bio Serv Inc (OTC-PBSV) is $0.60. This implies an estimated upside of 19.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 19.7% versus the current market price.

The available analyst price target for Pharma-Bio Serv Inc (OTC-PBSV) is $1.55. The analyst target implies estimated upside of 210.0%.

The current financial health read for Pharma-Bio Serv Inc (OTC-PBSV) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Pharma-Bio Serv Inc (OTC-PBSV) is September 16, 2026.

Based on the current data, dividend yield is 15.0%, upcoming dividend amount is 0.08.

The current P/E ratio listed for Pharma-Bio Serv Inc (OTC-PBSV) is 186.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Pharma-Bio Serv Inc is 11.451 M.

The current enterprise value listed for Pharma-Bio Serv Inc is 2.979 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Pharma-Bio Serv Inc is OTC-PBSV, and the stock is listed on OTC Markets.

Pharma-Bio Serv Inc (OTC-PBSV) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Pharma-Bio Serv Inc is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Pharma-Bio Serv Inc is 36.6%. Free float helps investors understand how much of the share base is available for public trading.

Similar Life Sciences Tools & Services Stocks on OTC Markets View more

Lonza Group AG (LZAGY) Lonza Group AG (LZAGY)
WuXi Biologics (WXIBF) WuXi Biologics (WXIBF)
RADNOSTIX, INC (INIS) RADNOSTIX, INC (INIS)
Malin Corporation plc (MLLNF) Malin Corporation plc (MLLNF)
Bioqual Inc (BIOQ) Bioqual Inc (BIOQ)
Sona Nanotech Inc (SNANF) Sona Nanotech Inc (SNANF)
Reflect Scientific Inc (RSCF) Reflect Scientific Inc (RSCF)
Cannabis Bioscience International Holdings Inc (CBIH) Cannabis Bioscience International Holdings Inc (CBIH)
BNB Plus Corp (BNBX) BNB Plus Corp (BNBX)
Pressure Biosciences Inc (PBIO) Pressure Biosciences Inc (PBIO)
EVIO Inc (EVIO) EVIO Inc (EVIO)
MetaStat Inc (MTST) MetaStat Inc (MTST)
Telesis Bio Inc (TBIO) Telesis Bio Inc (TBIO)
BG Medicine Inc (BGMD) BG Medicine Inc (BGMD)
Arrayit Corporation (ARYC) Arrayit Corporation (ARYC)
Response Genetics Inc (RGDXQ) Response Genetics Inc (RGDXQ)